Back to LCT Homepage Targeting Huntington's Disease, Stroke, Type 1 Diabetes and Haemophilia
Information about LCT Living Cell Technologies
LCT - Living Cell Technologies
News updates: Subscribe
Unsubscribe


May 8, 2008
LCT features on Channel Ten News
May 8, 2008
LCT prepares to list on international OTCQX
April 30, 2008
Appendi x4C - Quarterly results
April 2, 2008
LCT showcases proprietary nanotechnology
March 31, 2008
LCT announces compelling trial results
 

Media

May 2008

LCT features on Channel Ten News more
May 8, 2008

LCT prepares to list on international OTCQX more
May 8, 2008

April 2008

LCT showcases proprietary nanotechnology more
April 2, 2008

March 2008

LCT announces compelling trial results more
March 31, 2008

LCT receives US $6m in share capital more
March 19, 2008

LCT is issued 4th US patent more
March 17, 2008

January 2008

LCT features in Australian Investor magazine more
January 30, 2008

LCT announces conversion by noteholders more
January 25, 2008

November 2007

LCT Receives A$6.0M in Capital Placement more
November 30, 2007

LCT AGM Presentation more
November 27, 2007

LCT Updates shareholders on Clinical Trial Progress at AGM more
November 27, 2007

LCT to Cancel Rights At 20 cents more
November 22, 2007

LCT recieves initial Navigroup funding more
November 6, 2007

October 2007

LCT announces further $6.4m capital placement more
October 30, 2007

LCT presents at Rodman and Renshaw Healthcare conference more
October 23, 2007

Further positive preliminary data on Diabecell trial more
October 22, 2007

Positive preliminary data on DiabeCell phase I/IIa trial more
October 9, 2007

LCT to raise $2.4m with option to purchase up to $9.8m in placement by international investors more
October 3, 2007

September 2007

Receives Ethics Approval for Diabetes Clinical Trial more
September 12, 2007

August 2007

LCT to feature on ABC TV 7.30 report more
August 29, 2007

LCT appoints David Brookes as Independent Director more
August 23, 2007

Scientific Journal Publishes Increased Durability of
DiabeCell® Cell Therapy more
August 01, 2007

July 2007

LCT increases US investment support through launch of ADR program more
July 17, 2007

LCT receives $100k Enterprise Development Grant more
July 05, 2007

LCT U.S. Capabilities: Appoints The Channel Group to Lead Commercial and Capital Markets Initiatives July 2, 2007 more
July 02, 2007

June 2007

Diabetes Patient Successfully Transplanted in World-first
DiabeCell® Trial more
June 14, 2007

May 2007

LCT awarded world-first IANZ accreditation for xeno facilities more
May 22, 2007

LCT to present at US Venture Forum more
May 1, 2007

April 2007

Regulatory Review Allows LCT's Diabetes Clinical
Program to Proceed more
April 17, 2007

LCT to establish Level 1 American Depository Receipt Program more
April 12, 2007

Pig cells help to fight diabetes TV3 NZ News Feature link
April 2, 2007

March 2007

LCT reports major step forward for islet transplantation more
March 30, 2007

February 2007

Australian Investor Online - LCT beginning clinical trials more
February 9, 2007

LCT announces underwriting of share purchase plan more
February 2, 2007

January 2007

LCT to start clinical trial of Type 1 diabetes treatment more
January 30, 2007

LCT appoints CEO as Company Heads into New
Phase of Development more
January 24, 2007

LCT opens share purchase plan offer more
January 17, 2007

Archive 2006

Archive 2005

Archive 2004

LCT - Living Cell Technologies
What is xenotransplantation?
The use of living animal cells, tissues or organs in human therapeutics. >more

What is DiabeCell?
DiabeCell is a porcine pancreatic cell product for the treatment of insulin-dependent diabetes. >more

What is NeurotrophinCell?
A choroid plexus (brain) cell product with the potential to treat diseases of the nervous system such as Huntington's disease and stroke. >more

What is LCT's encapsulation technology?
The living cells are covered in a seaweed-derived coating (alginate encapsulation) to form capsules which eliminate the
need for toxic immunosuppressant drugs and allow the release of beneficial factors.
>more
   
graphic design and website design - PDF Communications Ltd